Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1987 Sep 19;295(6600):716-8.
doi: 10.1136/bmj.295.6600.716.

High incidence of hypoglycaemia in African patients treated with intravenous quinine for severe malaria

Affiliations

High incidence of hypoglycaemia in African patients treated with intravenous quinine for severe malaria

W Okitolonda et al. Br Med J (Clin Res Ed). .

Abstract

Changes in plasma glucose and insulin concentrations were monitored over 24 hours in 28 African patients receiving quinine intravenously in an average dose of 8.5 mg base/kg over one hour eight hourly for severe malaria. The patients (nine children and 19 adults) were moderately undernourished; none was pregnant or had renal insufficiency. Plasma insulin concentrations rose during the infusion and then declined. Plasma glucose concentrations were decreased at two, three, and four hours after the start of the infusion. Insulin: glucose ratios were raised between half an hour and two hours after the start of the infusion. The three infusions of quinine increased plasma insulin concentrations in a similar way. In nine patients, including four children, plasma glucose concentrations fell below 2.8 mmol/l on one or two occasions. At the time of the hypoglycaemia plasma insulin concentrations were inappropriately high as shown by a consistent and often considerable increase in the insulin:glucose ratio. Hypoglycaemia that may pass unnoticed in comatose patients is thus a common complication of treating severe malaria with quinine, in particular in children. Its high incidence calls for attentive monitoring and preventive measures.

PubMed Disclaimer

References

    1. FEBS Lett. 1975 Oct 1;57(3):280-4 - PubMed
    1. Scand J Clin Lab Invest. 1963;15:553-6 - PubMed
    1. Biochim Biophys Acta. 1981 Jan 8;640(1):16-30 - PubMed
    1. Endocrinology. 1982 Apr;110(4):1325-32 - PubMed
    1. Biochem Pharmacol. 1982 Apr 1;31(7):1407-15 - PubMed

Publication types

LinkOut - more resources